WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2015

Feb 24, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-02-23

Reporting Person: ZENNER PATRICK J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-23	Common Stock	M	6400.0000	$14.1250	Acquired	51254.9900	Direct
2015-02-23	Common Stock	M	6400.0000	$13.1850	Acquired	57654.9900	Direct
2015-02-23	Common Stock	S	12800.0000	$53.6900	Disposed	44854.9900	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-23	Stock Option (Right to Buy)	$13.1850	M	6400.0000	Disposed	2015-04-27	Common Stock (6400.0000)	Direct
2015-02-23	Stock Option (Right to Buy)	$14.1250	M	6400.0000	Disposed	2015-06-28	Common Stock (6400.0000)	Direct

Footnotes

F1: This was multiple transactions on the same date with prices in the range of $53.52 to $53.86. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.